Abstract
Objectives
In recent years, research on behavioral and psychiatric problems of adults with Prader-Willi syndrome (PWS) has gained attention. However, no report is available regarding the relationship between psychiatric illness and type 2 diabetes mellitus (T2DM) in patients with PWS. Therefore, we evaluated a behavioral assessment to address the lack of data on the association between psychiatric behavior and T2DM.
Methods
This was a retrospective single-center study of patients with PWS. Patients with PWS whose blood tests were performed in our hospital between January 2018 and December 2019 and aged >10 years were included. We evaluated the data, including the behavioral patterns of Japanese PWS patients with T2DM.
Results
Overall, 114 patients were evaluated; 33 patients (28.9%) developed T2DM. The age of T2DM onset was 18.0 years (interquartile range [IQR], 14.6–21.4 years). The median body mass index at T2DM onset was 33.7 kg/m2 (IQR, 30.0–37.4 kg/m2). Between-group comparisons of the intelligence quotient, Food-Related Problem Questionnaire (FRPQ), and Japanese versions of the Short Sensory Profile and Aberrant Behavior Checklist showed a significant difference only in FRPQ scores (p=0.003).
Conclusions
The occurrence of T2DM among Japanese patients with PWS remains high. Only the FRPQ was significantly different between the T2DM and the non-T2DM group.
Funding source: JSPS KAKENHI
Award Identifier / Grant number: 19K17375
Acknowledgments
We are grateful to the patients and their families for their willingness to participate in this study.
-
Research funding: This work was supported by JSPS KAKENHI Grant Number 19K17375.
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Competing interests: The funding organization(s) played no role in the study design, in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the report for publication.
-
Employment or leadership: None declared.
-
Honorarium: None declared.
-
Informed consent: Informed consent was obtained from all individuals included in this study.
-
Ethical approval: The local Institutional Review Board deemed the study exempt from review.
References
1. Butler, MG, Miller, JL, Forster, JL. Prader-Willi syndrome—clinical genetics, diagnosis and treatment approaches: an update. Curr Pediatr Rev 2019;15:207–44, https://doi.org/10.2174/1573396315666190716120925.Search in Google Scholar PubMed PubMed Central
2. Cassidy, SB, Schwartz, S, Miller, JL, Driscoll, DJ. Prader-Willi syndrome. Genet Med 2012;14:10–26, https://doi.org/10.1038/gim.0b013e31822bead0.Search in Google Scholar PubMed
3. Lionti, T, Reid, SM, White, SM, Rowell, MM. A population-based profile of 160 Australians with Prader-Willi syndrome: trends in diagnosis, birth prevalence and birth characteristics. Am J Med Genet A 2015;167:371–8, https://doi.org/10.1002/ajmg.a.36845.Search in Google Scholar PubMed
4. Crino, A, Di Giorgio, G, Livieri, C, Grugni, G, Beccaria, L, Bosio, L, et al.. A survey on Prader-Willi syndrome in the Italian population: prevalence of historical and clinical signs. J Pediatr Endocrinol Metab 2009;22:883–93, https://doi.org/10.1515/jpem.2009.22.10.883.Search in Google Scholar PubMed
5. Ma, Y, Wu, T, Liu, Y, Wang, Q, Song, J, Song, F, et al.. Nutritional and metabolic findings in patients with Prader-Willi syndrome diagnosed in early infancy. J Pediatr Endocrinol Metab 2012;25:1103–9, https://doi.org/10.1515/jpem-2012-0167.Search in Google Scholar PubMed
6. Crinò, A, Fintini, D, Bocchini, S, Grugni, G. Obesity management in Prader-Willi syndrome: current perspectives. Diabetes Metab Syndr Obes 2018;4:579–93, https://doi.org/10.2147/DMSO.S141352.Search in Google Scholar PubMed PubMed Central
7. Deal, CL, Tony, M, Höybye, C, Allen, DB, Tauber, M, Christiansen, JS. Growth Hormone in Prader-Willi syndrome clinical care guidelines workshop participants. Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab 2013;98:E1072–87, https://doi.org/10.1210/jc.2012-3888.Search in Google Scholar PubMed PubMed Central
8. Carrel, AL, Myers, SE, Whitman, BY, Eickhoff, J, Allen, DB. Long-term growth hormone therapy changes the natural history of body composition and motor function in children with Prader-Willi syndrome. J Clin Endocrinol Metab 2010;95:1131–6, https://doi.org/10.1210/jc.2009-1389.Search in Google Scholar PubMed PubMed Central
9. Whittington, JE, Holland, AJ, Webb, T. Ageing in people with Prader-Willi syndrome: mortality in the UK population cohort and morbidity in an older sample of adults. Psychol Med 2015;45:615–21, https://doi.org/10.1017/s0033291714001755.Search in Google Scholar PubMed
10. Tsuchiya, T, Oto, Y, Ayabe, T, Obata, K, Murakami, N, Nagai, T. Characterization of diabetes mellitus in Japanese Prader-Willi syndrome. Clin Pediatr Endocrinol 2011;20:33–8, https://doi.org/10.1297/cpe.20.33.Search in Google Scholar PubMed PubMed Central
11. Dykens, EM, Roof, E. Behavior in Prader-Willi syndrome: relationship to genetic subtypes and age. J Child Psychol Psychiatry 2008;49:1001–8, https://doi.org/10.1111/j.1469-7610.2008.01913.x.Search in Google Scholar
12. Schwartz, L, Caixàs, A, Dimitropoulos, A, Dykens, E, Duis, J, Einfeld, et al.. Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the international PWS clinical trial consortium. J Neurodev Disord 2021;21:25, https://doi.org/10.1186/s11689-021-09373-2.Search in Google Scholar
13. Kato, N, Sato, K, Takimoto, H, Sudo, N. BMI for age references for Japanese children-Based on the 2000 growth survey. Asia Pac J Public Health 2008;20:118–27.Search in Google Scholar
14. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care 2018;39:S13–22.10.2337/dc16-S005Search in Google Scholar
15. Fukuda, M. Classification and treatment of diabetic retinopathy. Diabetes Res Clin Pract 1994;24:S171–6, https://doi.org/10.1016/0168-8227(94)90246-1.Search in Google Scholar
16. Donaghue, KC, Chiarelli, F, Trotta, D, Allgrove, J, Dahl-Jorgensen, K. Microvascular and macrovascular complications associated with diabetes in children and adolescents. Pediatr Diabetes 2009;10:195–203, https://doi.org/10.1111/j.1399-5448.2009.00576.x.Search in Google Scholar PubMed
17. Unger, T, Borghi, C, Charchar, F, Khan, NA, Poulter, NR, Prabhakaran, D, et al.. International society of hypertension global hypertension practice guidelines. Hypertension 2020;75:1334–57, https://doi.org/10.1161/hypertensionaha.120.15026.Search in Google Scholar
18. Flynn, JT, Kaelber, DC, Baker-Smith, CM, Blowey, D, Carroll, AE, Daniels, SR, et al.. Subcommittee on screening and management of high blood pressure in children. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 2017;140: e20171904, https://doi.org/10.1542/peds.2017-1904.Search in Google Scholar PubMed
19. Wechsler, D. The Wechslar Intelligence Scale for Children, 3rd ed. Sun Antonio, TX: The Psychological Corporation; 1991.Search in Google Scholar
20. Wechsler, D. Wechsler Adult Intelligence Scale, 3rd ed. San Antonio, TX: The Psychological Corporation; 1997.10.1037/t49755-000Search in Google Scholar
21. Dunn, W. Sensory profile’s user manual. San Antonio, TX: The Psychological Corporation; 1999.10.1037/t15155-000Search in Google Scholar
22. McIntosh, DN, Miller, LJ, Shyu, V, Dunn, W. Overview of the short sensory profile. In: Dunn, W, editor Sensory profile user’s manual 1999. San Antonio: Pearsons. pp. 59–73.Search in Google Scholar
23. Russell, H, Oliver, C. The assessment of food-related problems in individuals with Prader-Willi syndrome. Br J Clin Psychol 2003;42:379–92, https://doi.org/10.1348/014466503322528928.Search in Google Scholar PubMed
24. Brinkley, J, Nations, L, Abramson, RK, Hall, A, Wright, HH, Gabriels, R, et al.. Factor analysis of the aberrant behavior checklist in individuals with autism spectrum disorders. J Autism Dev Disord 2007;37:1949–59, https://doi.org/10.1007/s10803-006-0327-3.Search in Google Scholar
25. Kanda, Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 2013;48:452–8, https://doi.org/10.1038/bmt.2012.244.Search in Google Scholar
26. Kuzuya, T. New classification and diagnostic criteria of diabetes mellitus by the Japan diabetes society. Asian Med J 2001;44:49–56.Search in Google Scholar
27. Anhalt, H, Eckert, KH, Hintz, RL, Neely, EK. Type I diabetes mellitus, ketoacidosis and thromboembolism in an adolescent with Prader-Willi syndrome. Acta Paediatr 1996;85:516, https://doi.org/10.1111/j.1651-2227.1996.tb14076.x.Search in Google Scholar
28. Bassali, R, Hoffman, WH, Chen, H, Tuck-Muller, CM. Hyperlipidemia, insulin-dependent diabetes mellitus, and rapidly progressive diabetic retinopathy and nephropathy in Prader-Willi syndrome with del (15) (q11.2q13). Am J Med Genet 1997;22:267–70, https://doi.org/10.1002/(sici)1096-8628(19970822)71:3<267::aid-ajmg3>3.0.co;2-r.10.1002/(SICI)1096-8628(19970822)71:3<267::AID-AJMG3>3.0.CO;2-RSearch in Google Scholar
29. Crinò, A, Grugni, G. Update on diabetes mellitus and glucose metabolism alterations in Prader-Willi syndrome. Curr Diab Rep 2020;20:7, https://doi.org/10.1007/s11892-020-1284-5.Search in Google Scholar
30. Yang, A, Kim, J, Cho, SY, Jin, DK. Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience. Orphanet J Rare Dis 2017;12:146, https://doi.org/10.1186/s13023-017-0702-5.Search in Google Scholar
31. Hedgeman, E, Ulrichsen, SP, Carter, S, Kreher, NC, Malobisky, KP, Braun, MM, et al.. Long-term health outcomes in patients with Prader-Willi Syndrome: a nationwide cohort study in Denmark. Int J Obes 2017;41:1531–8, https://doi.org/10.1038/ijo.2017.139.Search in Google Scholar
32. Fintini, D, Grugni, G, Bocchini, S, Brufani, C, Di Candia, S, Corrias, A, et al.. Genetic obesity study group of the Italian society of pediatric endocrinology and diabetology (ISPED). Disorders of glucose metabolism in Prader-Willi syndrome: results of a multicenter Italian cohort study. Nutr Metab Cardiovasc Dis 2016;26:827–42, https://doi.org/10.1016/j.numecd.2016.05.010.Search in Google Scholar
33. Sinnema, M, Schrander-Stumpel, CT, Maaskant, MA, Boer, H, Curfs, LM. Aging in Prader-Willi syndrome: twelve persons over the age of 50 years. Am J Med Genet A 2012;158:1326–36, https://doi.org/10.1002/ajmg.a.35333.Search in Google Scholar
34. Laurier, V, Lapeyrade, A, Copet, P, Demeer, G, Silvie, M, Bieth, E, et al.. Medical, psychological and social features in a large cohort of adults with Prader-Willi syndrome: experience from a dedicated centre in France. J Intellect Disabil Res 2015;59:411–21, https://doi.org/10.1111/jir.12140.Search in Google Scholar
35. Sone, H, Ito, H, Ohashi, Y, Akanuma, Y, Yamada, N. Japan diabetes complication study group. Obesity and type 2 diabetes in Japanese patients. Lancet 2013;361:85, https://doi.org/10.1016/S0140-6736(03)12151-4.Search in Google Scholar
36. Cheng, YJ, Kanaya, AM, Araneta, MR, Saydah, SH, Kahn, HS, Gregg, EW, et al.. Prevalence of diabetes by race and Ethnicity in the United States, 2011-2016. J Am Med Assoc 2019;322:2389–98, https://doi.org/10.1001/jama.2019.19365.Search in Google Scholar PubMed PubMed Central
37. Kodama, K, Tojjar, D, Yamada, S, Toda, K, Patel, CJ, Butte, AJ. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis. Diabetes Care 2013;36:1789–96, https://doi.org/10.2337/dc12-1235.Search in Google Scholar PubMed PubMed Central
38. Shai, I, Jiang, R, Manson, JE, Stampfer, MJ, Willett, WC, Colditz, GA, et al.. Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care 2006;29:1585–90, https://doi.org/10.2337/dc06-0057.Search in Google Scholar PubMed
39. The 2018 National Health and Nutrition Survey. National Institute of health and Nutrition; Labor and Welfare. Available at: https://www.nibiohn.go.jp/eiken/kenkounippon21/download_files/eiyouchousa/2018.pdf.Search in Google Scholar
40. Morita, A, Ishigaki, Y. Gender-difference in diabetes mellitus. Nihon Rinsho 2015;73:606–10. (In Japanese).Search in Google Scholar
41. Ding, EL, Song, Y, Malik, VS, Liu, S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. J Am Med Assoc 2006;15:1288–99, https://doi.org/10.1001/jama.295.11.1288.Search in Google Scholar PubMed
42. Gito, M, Ihara, H, Ogata, H, Sayama, M, Murakami, N, Nagai, T, et al.. Gender differences in the behavioral symptom severity of Prader-Willi syndrome. Behav Neurol 2015:294127, https://doi.org/10.1155/2015/294127.Search in Google Scholar PubMed PubMed Central
43. Coupaye, M, Lorenzini, F, Lloret-Linares, C, Molinas, C, Pinto, G, Diene, G, et al.. Growth hormone therapy for children and adolescents with Prader-Willi syndrome is associated with improved body composition and metabolic status in adulthood. J Clin Endocrinol Metab 2013;98:E328–35, https://doi.org/10.1210/jc.2012-2881.Search in Google Scholar PubMed
44. Ishii, A, Ihara, H, Ogata, H, Sayama, M, Gito, M, Murakami, N, et al.. Autistic, aberrant, and food-related behaviors in adolescents and young adults with Prader-Willi syndrome: the effects of age and genotype. Behav Neurol 2017:4615451, https://doi.org/10.1155/2017/4615451.Search in Google Scholar PubMed PubMed Central
45. Goldstone, AP, Holland, AJ, Hauffa, BP, Hokken-Koelega, AC, Tauber, M. Speakers contributors at the second expert meeting of the comprehensive care of patients with PWS. Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab; 2008;93:4183–97, https://doi.org/10.1210/jc.2008-0649.Search in Google Scholar PubMed
46. Horikawa, Y, Enya, M, Komagata, M, Hashimoto, KI, Kagami, M, Fukami, M, et al.. Effectiveness of sodium-glucose cotransporter-2 inhibitor as an add-on drug to GLP-1 receptor agonists for glycemic control of a patient with Prader-Willi syndrome: a case report. Diabetes Ther 2018;9:421–6, https://doi.org/10.1007/s13300-018-0369-5.Search in Google Scholar PubMed PubMed Central
47. Sano, H, Kudo, E, Yamazaki, T, Ito, T, Hatakeyama, K, Kawamura, N. Efficacy of sodium-glucose cotransporter 2 inhibitor with glucagon-like peptide-1 receptor agonist for the glycemic control of a patient with Prader-Willi syndrome: a case report. Clin Pediatr Endocrinol 2020;29:81–4, https://doi.org/10.1297/cpe.29.81.Search in Google Scholar PubMed PubMed Central
48. Whittington, J, Holland, A, Webb, T, Butler, J, Clarke, D, Boer, H. Cognitive abilities and genotype in a population-based sample of people with Prader-Willi syndrome. J Intellect Disabil Res 2004;48:172–87, https://doi.org/10.1111/j.1365-2788.2004.00556.x.Search in Google Scholar PubMed
49. Zickgraf, HF, Richard, E, Zucker, NL, Wallace, GL. Rigidity and sensory sensitivity: independent contributions to selective eating in children, adolescents, and young adults. J Clin Child Adolesc Psychol 2020;19:1–13, https://doi.org/10.1080/15374416.2020.1738236.Search in Google Scholar PubMed
50. Engel-Yeger, B, Muzio, C, Rinosi, G, Solano, P, Geoffroy, PA, Pompili, M, et al.. Extreme sensory processing patterns and their relations with clinical conditions among individuals with major affective disorders. Psychiatry Res 2016;28:112–8, https://doi.org/10.1016/j.psychres.2015.12.022.Search in Google Scholar PubMed
© 2021 Walter de Gruyter GmbH, Berlin/Boston
